Omalizumab

Omalizumab

Omalizumab is a recombinant humanized monoclonal antibody against human immunoglobulin E IgE)

 

 

[accordions]
[accordion title= “Chemical Properties“]

Molecular Weight 149 kDa
CAS No. 242138-07-4

[/accordion]

 

 

 

[accordions]
[accordion title= “References and Literature“]

1. Chan MA, et al.Omalizumab may decrease IgE synthesis by targeting membrane IgE+ human B cells.Clin Transl Allergy. 2013 Sep 2;3(1):29.

[/accordion]